Skip to main content

Introduction to Modern Cancer Diagnosis and Survivorship

  • 95 Accesses

Abstract

This chapter gives the reader an overview of cancer diagnosis and what it means to be a cancer survivor. It also briefly explains the future and challenges in supportive care in cancer in the era of precision oncology.

Keywords

  • Cancer
  • Survivorship
  • Precision oncology

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-3-030-86510-8_1
  • Chapter length: 9 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   139.00
Price excludes VAT (USA)
  • ISBN: 978-3-030-86510-8
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Hardcover Book
USD   179.99
Price excludes VAT (USA)
Fig. 1.1

Bibliography

  1. Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

    CrossRef  Google Scholar 

  2. AACR 2018 Annual Report.

    Google Scholar 

  3. Ahn J, et al. Oral microbiome and oral and gastrointestinal cancer risk. Cancer Causes Control. 2012;23:399–404.

    CrossRef  Google Scholar 

  4. Islami F, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68:31–54.

    CrossRef  Google Scholar 

  5. Gapstur SM, et al. A blueprint for the primary prevention of cancer: targeting established, modifiable risk factors. CA Cancer J Clin. 2018;68:446–70.

    CrossRef  Google Scholar 

  6. Jamal A, et al. Current cigarette smoking among adults—United States 2016. MMWR Morb Mortal Wkly Rep. 2018;67:53–9.

    CrossRef  Google Scholar 

  7. Neri A, et al. Radon control activities for lung cancer prevention in National Comprehensive Cancer Control Program Plans, 2005–2011. Prevent Chronic Dis. 2013;10:120337.

    CrossRef  Google Scholar 

  8. Lehmann U, Bartels S. Liquid biopsy in tumor diagnostics. Pathologe. 2019; https://doi.org/10.1007/s00292-019-0604-5.

  9. Stobiecka M, Ratajczak K, Jakiela S. Toward early cancer detection: focus on biosensing systems and biosensors for an anti-apoptotic protein survivin and survivin mRNA. Biosens Bioelectron. 2019;137:58–71. https://doi.org/10.1016/j.bios.2019.04.060. [Epub ahead of print].

    CrossRef  PubMed  Google Scholar 

  10. Hung KF, et al. MicroRNA-31 upregulation predicts increased risk of progression of oral potentially malignant disorder. Oral Oncol. 2016;53:42–7.

    CrossRef  Google Scholar 

  11. Sharma DC. Salivary bacteria linked to oral cancers. Lancet Oncol. 2005;6:547.

    CrossRef  Google Scholar 

  12. Herrero R, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003;95:1772–83.

    CrossRef  Google Scholar 

  13. Sohrabi M, Nair RG, Samaranayake LP, et al. The yield and quality of cellular and bacterial DNA extracts from human oral rinse samples are variably affected by the cell lysis methodology. J Microbiol Methods. 2016;122:64–72.

    CrossRef  Google Scholar 

  14. Fadhil RS, Wei MQ, Nikolarakos D, Good D, Nair RG. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic biomarkers for head and neck squamous cell carcinoma. PLoS One. 2020;15(3):e0221779. https://doi.org/10.1371/journal.pone.0221779. eCollection 2020.

  15. Fadhil R, Nair RG, Nikolarakos D, Wei M. Next Generation Sequencing Identifies Novel Diagnostic Biomarkers for Head and Neck Squamous Cell Carcinoma. Oral Cancer. 2019; https://doi.org/10.1007/s41548-019-00019-5.

  16. Tsimberidou AM, et al. Review of precision cancer medicine: evolution of the treatment paradigm. Cancer Treat Rev. 2020;86:102019.

    CrossRef  Google Scholar 

  17. Al-Samadi A, et al. In vitro humanized 3D microfluidic chip for testing personalized immunotherapeutics for head and neck cancer patients. Exp Cell Res. 2019;383:111508.

    CrossRef  Google Scholar 

  18. Wang Y, et al. Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck carcinomas. Sci Transl Med. 2015;7:293ra104.

    PubMed  PubMed Central  Google Scholar 

  19. Nor JE, Gutkind JS. Head and Neck Cancer in the new era of precision medicine. J Dent Res. 2018;97:601–2.

    CrossRef  Google Scholar 

  20. Agrawal N, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011;333:1154–7.

    CrossRef  Google Scholar 

  21. Polverini PJ, et al. Precision therapy of head and neck squamous cell carcinoma. J Dent Res. 2018;97:614–21.

    CrossRef  Google Scholar 

  22. Bachour P, Sonis ST. Predicting the risk of mucositis associated with cytotoxic cancer treatment regimens: rationale, complexity and challenges. Curr Opin Support Palliat Care. 2018;12:1998–210.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Raj Nair .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Verify currency and authenticity via CrossMark

Cite this chapter

Nair, R., Nair, R., Sonis, S.T. (2022). Introduction to Modern Cancer Diagnosis and Survivorship. In: Nair, R. (eds) Orofacial Supportive Care in Cancer . Springer, Cham. https://doi.org/10.1007/978-3-030-86510-8_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-86510-8_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-86509-2

  • Online ISBN: 978-3-030-86510-8

  • eBook Packages: MedicineMedicine (R0)